Doriane Aguanno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Doriane Aguanno has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Dirk Haller
Technical University of Munich
4 shared publications - Tina Krammel
Chair of Nutrition and Immunology, Technical University of Munich, Freising, Germany
3 shared publications - Amira Metwaly
Technical University of Munich
2 shared publications - Deborah Häcker
Chair of Nutrition and Immunology, Technical University of Munich, Freising, Germany
2 shared publications - Elisabeth Urbauer
Chair of Nutrition and Immunology, Technical University of Munich, Freising, Germany
2 shared publications - Eva Rath
Department of Nutrition and Immunology, School of Life Sciences, Technical University of Munich, Freising, Germany
2 shared publications
Latest Publications
- 4 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Modulation de la fonction de barrière intestinale et des jonctions serrées par les N-acyl homosérine lactones, molécules du quorum sensing bactérien
L'intestin abrite le principal microbiote du corps humain et exerce donc un rôle de barrière. Les jonctions serrées (JS) contrôlent la perméabilité paracellulaire des cellules épithéliales et sont des acteurs majeurs de la barrière intestinale, dérégulée dans les Maladies Inflammatoires Chroniques de l'Intestin (MICI). Les N-acyl homosérine lactones (AHL), molécules du quorum sensing, un système bactérien de communication, sont également capables d’interagir avec l'hôte. Nous avons récemment identifié l'AHL 3-oxo-C12:2, diminuée dans les MICI. Notre objectif est d’étudier l’impact de cette nouvelle AHL sur la fonction de barrière intestinale et de le comparer à celui de l’AHL 3-oxo-C12 de Pseudomonas aeruginosa, connue pour ses effets délétères sur les barrières épithéliales. Dans la lignée humaine entérocytaire Caco-2/TC7, alors qu'en présence de 3-oxo-C12, la perméabilité paracellulaire est augmentée et le signal de l’occludine et tricelluline est diminuée aux JS bicellulaires et tricellulaires respectivement, la 3-oxo-C12:2 ne modifie ni la perméabilité ni l’organisation des JS. Alors que la 3-oxo-C12 potentialise l’augmentation de la perméabilité induite par l'Interféron-γ et le Tumor Necrosis Factor, la 3-oxo-C12:2 atténue les effets délétères des cytokines sur l'occludine et la tricelluline. De plus, elle préserve la stabilité des complexes jonctionnels à la membrane plasmique en réduisant l’ubiquitination des protéines de JS augmentée par les cytokines. Ainsi, les effets potentiellement protecteurs de la 3-oxo-C12:2 sur la barrière intestinale constitue une nouvelle piste pour mieux comprendre les interactions hôte-microbiote mises en jeu dans les MICI.
- 4 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Modulation de la fonction de barrière intestinale et des jonctions serrées par les N-acyl homosérine lactones, molécules du quorum sensing bactérien
L'intestin abrite le principal microbiote du corps humain et exerce donc un rôle de barrière. Les jonctions serrées (JS) contrôlent la perméabilité paracellulaire des cellules épithéliales et sont des acteurs majeurs de la barrière intestinale, dérégulée dans les Maladies Inflammatoires Chroniques de l'Intestin (MICI). Les N-acyl homosérine lactones (AHL), molécules du quorum sensing, un système bactérien de communication, sont également capables d’interagir avec l'hôte. Nous avons récemment identifié l'AHL 3-oxo-C12:2, diminuée dans les MICI. Notre objectif est d’étudier l’impact de cette nouvelle AHL sur la fonction de barrière intestinale et de le comparer à celui de l’AHL 3-oxo-C12 de Pseudomonas aeruginosa, connue pour ses effets délétères sur les barrières épithéliales. Dans la lignée humaine entérocytaire Caco-2/TC7, alors qu'en présence de 3-oxo-C12, la perméabilité paracellulaire est augmentée et le signal de l’occludine et tricelluline est diminuée aux JS bicellulaires et tricellulaires respectivement, la 3-oxo-C12:2 ne modifie ni la perméabilité ni l’organisation des JS. Alors que la 3-oxo-C12 potentialise l’augmentation de la perméabilité induite par l'Interféron-γ et le Tumor Necrosis Factor, la 3-oxo-C12:2 atténue les effets délétères des cytokines sur l'occludine et la tricelluline. De plus, elle préserve la stabilité des complexes jonctionnels à la membrane plasmique en réduisant l’ubiquitination des protéines de JS augmentée par les cytokines. Ainsi, les effets potentiellement protecteurs de la 3-oxo-C12:2 sur la barrière intestinale constitue une nouvelle piste pour mieux comprendre les interactions hôte-microbiote mises en jeu dans les MICI.
- Open Access
- 11 November 2025
- Published by Springer Nature in Seminars in Immunopathology
- Vol. 47 (1) , 40
Correction: Therapeutic mechanisms of exclusive enteral nutrition in crohn’s disease
- 11 November 2025
- Published by Springer Nature in Seminars in Immunopathology
- Vol. 47 (1) , 40
Open AccessCorrection: Therapeutic mechanisms of exclusive enteral nutrition in crohn’s disease
- Open Access
- 2 July 2025
- Published by Springer Nature in Seminars in Immunopathology
- Vol. 47 (1) , 28
Therapeutic mechanisms of exclusive enteral nutrition in Crohn’s disease
Crohn’s disease (CD) is a chronic, relapsing multifactorial inflammatory condition of the gastrointestinal tract, which is diagnosed under the age of 17 in 25% of patients, categorized as pediatric CD (pCD). Exclusive enteral nutrition (EEN) is a first-line therapy for inducing remission in pCD, yet its precise mechanisms remain poorly understood. This review summarizes the complex interplay of EEN-induced protective changes in the gut microbiota, epithelial barrier function and mucosal immune responses. EEN reshapes the gut microbiome by excluding potential pathobionts from the gut mucus layer and increasing protective bacterial and dietary metabolites. Emerging evidence highlights the role of EEN in modulating mitochondrial function, tryptophan metabolism and other metabolites in the intestinal epithelium and immune cells, which may contribute to its therapeutic efficacy. However, high variability in microbiome responses across clinical cohorts and discrepancies between clinical trials and animal models warrant further research to identify functional consequences and therapeutic mechanisms of EEN.
- 2 July 2025
- Published by Springer Nature in Seminars in Immunopathology
- Vol. 47 (1) , 28
Open AccessTherapeutic mechanisms of exclusive enteral nutrition in Crohn’s disease
Crohn’s disease (CD) is a chronic, relapsing multifactorial inflammatory condition of the gastrointestinal tract, which is diagnosed under the age of 17 in 25% of patients, categorized as pediatric CD (pCD). Exclusive enteral nutrition (EEN) is a first-line therapy for inducing remission in pCD, yet its precise mechanisms remain poorly understood. This review summarizes the complex interplay of EEN-induced protective changes in the gut microbiota, epithelial barrier function and mucosal immune responses. EEN reshapes the gut microbiome by excluding potential pathobionts from the gut mucus layer and increasing protective bacterial and dietary metabolites. Emerging evidence highlights the role of EEN in modulating mitochondrial function, tryptophan metabolism and other metabolites in the intestinal epithelium and immune cells, which may contribute to its therapeutic efficacy. However, high variability in microbiome responses across clinical cohorts and discrepancies between clinical trials and animal models warrant further research to identify functional consequences and therapeutic mechanisms of EEN.
- Open Access
Reduced intestinal GLP-1 + cell numbers are associated with an inflammation-related epithelial metabolic signature
Background & Aims: Enteroendocrine cells (EECs) are known for their role in digestion and metabolism, yet their role in intestinal inflammation remains unclear. In inflammatory bowel diseases (IBD), a contribution of EECs to pathogenesis is indicated by autoantibodies affecting EEC function and general disease symptoms like insulin resistance and altered intestinal motility. Particularly, the L cell-derived hormone glucagon-like peptide 1 (GLP-1), suggested to orchestrate metabolic-inflammatory responses may influence inflammatory pathways in the intestine. Methods: We quantified numbers of GLP-1 + cells in 4 different mouse models of intestinal inflammation and performed transcriptional analyses of colonic epithelial cells from inflamed interleukin (IL)10-deficient mice. Using a publicly available single-cell RNA sequencing dataset including mucosal biopsies from Crohn’s disease (CD) patients, we confirmed findings from the murine models. A model of mitochondrial dysfunction (ClpP ΔIEC mice) as well as murine and human intestinal organoids were used to study molecular mechanisms. Results: Numbers of GLP-1 expressing cells are consistently reduced at the site of active disease in mouse models and CD patients. Despite this reduction, L cells from inflamed IL-10-deficient mice remained functional regarding GLP-1 secretion. Transcriptional analyses of intestinal epithelial cells indicate altered differentiation correlating with an inflammatory metabolic fingerprint. Reduced GLP-1 + cells in ClpP ΔIEC mice and inhibition of respiration in organoid cultures supports a causative role for metabolism in steering differentiation. Conclusion: Reduction of GLP-1 + cells represents a general feature of ileal and colonic inflammation in mice and human. Given the numerous properties of GLP-1, this reduction likely affects inflammatory processes in the mucosa and disease-related symptoms on multiple levels, and therefore, should be considered a therapeutic target in IBD. Data Transparency: All data generated or analyzed during this study are included in this published article. Additional datasets, including raw data, are available from the corresponding author upon reasonable request. Synopsis: This study examines GLP-1 + cells in intestinal inflammation, showing consistent reductions in inflamed areas. Findings from mouse models and human data reveal an inflammatory metabolic profile linked to altered epithelial differentiation. GLP-1, involved in endocrine-immune crosstalk, may impact mucosal inflammation and symptoms, making it a therapeutic target. Graphical
Open AccessReduced intestinal GLP-1 + cell numbers are associated with an inflammation-related epithelial metabolic signature
Background & Aims: Enteroendocrine cells (EECs) are known for their role in digestion and metabolism, yet their role in intestinal inflammation remains unclear. In inflammatory bowel diseases (IBD), a contribution of EECs to pathogenesis is indicated by autoantibodies affecting EEC function and general disease symptoms like insulin resistance and altered intestinal motility. Particularly, the L cell-derived hormone glucagon-like peptide 1 (GLP-1), suggested to orchestrate metabolic-inflammatory responses may influence inflammatory pathways in the intestine. Methods: We quantified numbers of GLP-1 + cells in 4 different mouse models of intestinal inflammation and performed transcriptional analyses of colonic epithelial cells from inflamed interleukin (IL)10-deficient mice. Using a publicly available single-cell RNA sequencing dataset including mucosal biopsies from Crohn’s disease (CD) patients, we confirmed findings from the murine models. A model of mitochondrial dysfunction (ClpP ΔIEC mice) as well as murine and human intestinal organoids were used to study molecular mechanisms. Results: Numbers of GLP-1 expressing cells are consistently reduced at the site of active disease in mouse models and CD patients. Despite this reduction, L cells from inflamed IL-10-deficient mice remained functional regarding GLP-1 secretion. Transcriptional analyses of intestinal epithelial cells indicate altered differentiation correlating with an inflammatory metabolic fingerprint. Reduced GLP-1 + cells in ClpP ΔIEC mice and inhibition of respiration in organoid cultures supports a causative role for metabolism in steering differentiation. Conclusion: Reduction of GLP-1 + cells represents a general feature of ileal and colonic inflammation in mice and human. Given the numerous properties of GLP-1, this reduction likely affects inflammatory processes in the mucosa and disease-related symptoms on multiple levels, and therefore, should be considered a therapeutic target in IBD. Data Transparency: All data generated or analyzed during this study are included in this published article. Additional datasets, including raw data, are available from the corresponding author upon reasonable request. Synopsis: This study examines GLP-1 + cells in intestinal inflammation, showing consistent reductions in inflamed areas. Findings from mouse models and human data reveal an inflammatory metabolic profile linked to altered epithelial differentiation. GLP-1, involved in endocrine-immune crosstalk, may impact mucosal inflammation and symptoms, making it a therapeutic target. Graphical
- Open Access
Mitochondrial perturbation in the intestine causes microbiota-dependent injury and gene signatures discriminative of inflammatory disease
Summary: Mitochondrial dysfunction is associated with inflammatory bowel diseases (IBD). To understand how microbial-metabolic circuits contribute to intestinal tissue injury, we disrupt mitochondrial function in the epithelium by deleting heat shock protein 60 (Hsp60 Δ/ΔIEC ). While metabolic perturbation causes self-resolving tissue injury, regeneration is disrupted in the absence of aryl hydrocarbon receptor (Hsp60 Δ/ΔIEC ;AhR -/- ) or IL-10 (Hsp60 Δ/ΔIEC ;Il10 -/- ) leading to IBD-like pathology. Injury is absent in the distal colon of germ-free (GF) Hsp60 Δ/ΔIEC mice, highlighting bacterial control of metabolic injury. Selective colonization of GF Hsp60 Δ/ΔIEC mice with the synthetic community OMM 12 confirms consistent expansion of metabolically-flexible Bacteroides spp. across all models and mono-colonization with B. caecimuris recapitulates injury. Transcriptional profiling of metabolically-impaired epithelium identifies gene signatures, including Ido1 , Nos2 , and Duox2 , distinguishing active from inactive tissue inflammation in 343 resected samples from Crohn’s disease patients. In conclusion, mitochondrial perturbation of the epithelium causes microbiota-dependent tissue injury and discriminative inflammatory gene profiles relevant for IBD. Abstract Figure: Graphical Control of metabolic injury by microbial signals.: Mitochondrial perturbation of the intestinal epithelium induces tissue injury Loss of IL-10 and AhR-related host mechanisms accelerate injury and inflammation Mitochondrial dysfunction induces dysbiosis and expansion of Bacteroides spp. Metabolic injury gene signature discriminates inflamed vs. non-inflamed IBD samples
Open AccessMitochondrial perturbation in the intestine causes microbiota-dependent injury and gene signatures discriminative of inflammatory disease
Summary: Mitochondrial dysfunction is associated with inflammatory bowel diseases (IBD). To understand how microbial-metabolic circuits contribute to intestinal tissue injury, we disrupt mitochondrial function in the epithelium by deleting heat shock protein 60 (Hsp60 Δ/ΔIEC ). While metabolic perturbation causes self-resolving tissue injury, regeneration is disrupted in the absence of aryl hydrocarbon receptor (Hsp60 Δ/ΔIEC ;AhR -/- ) or IL-10 (Hsp60 Δ/ΔIEC ;Il10 -/- ) leading to IBD-like pathology. Injury is absent in the distal colon of germ-free (GF) Hsp60 Δ/ΔIEC mice, highlighting bacterial control of metabolic injury. Selective colonization of GF Hsp60 Δ/ΔIEC mice with the synthetic community OMM 12 confirms consistent expansion of metabolically-flexible Bacteroides spp. across all models and mono-colonization with B. caecimuris recapitulates injury. Transcriptional profiling of metabolically-impaired epithelium identifies gene signatures, including Ido1 , Nos2 , and Duox2 , distinguishing active from inactive tissue inflammation in 343 resected samples from Crohn’s disease patients. In conclusion, mitochondrial perturbation of the epithelium causes microbiota-dependent tissue injury and discriminative inflammatory gene profiles relevant for IBD. Abstract Figure: Graphical Control of metabolic injury by microbial signals.: Mitochondrial perturbation of the intestinal epithelium induces tissue injury Loss of IL-10 and AhR-related host mechanisms accelerate injury and inflammation Mitochondrial dysfunction induces dysbiosis and expansion of Bacteroides spp. Metabolic injury gene signature discriminates inflamed vs. non-inflamed IBD samples